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Huntington’s disease (HD) is a genetically inherited neurodegenerative disorder caused by 
expansion of a polyglutamine (polyQ) repeats in the exon-1 of huntingtin protein (HTT). The 
expanded polyQ enhances the amyloidogenic propensity of HTT exon 1 (HTTex1), which forms 
a heterogeneous mixture of assemblies with some being neurotoxic. While predominantly 
intracellular, monomeric and aggregated mutant HTT species are also present in the 
cerebrospinal fluids of HD patients, however, their biological properties are not well understood. 
To explore the role of extracellular mutant HTT in aggregation and toxicity, we investigated the 
possible uptake and amplification of recombinant HTTex1 assemblies in cell culture models. We 
found seeding-competent species in the sonicated HTTex1 fibrils, which preferentially entered 
human neurons and triggered the amplification of neurotoxic assemblies; astrocytes or epithelial 
cells were not permissive to the HTTex1 seeding. The aggregation of HTTex1 seeds in neurons 
depleted endogenous HTT protein with non-pathogenic polyQ repeat, activated apoptotic 
caspase-3 pathway and induced nuclear fragmentation. Using a panel of novel monoclonal 
antibodies and genetic mutation, we identified epitopes within the N-terminal 17 amino acids and 
proline-rich domain of HTTex1 mediating neural seeding. Synaptosome preparations from the 
brains of HD mice also contained similar neurotoxic seeding-competent mutant HTT species. 
Our findings suggest that amyloidogenic extracellular mutant HTT assemblies may selectively 
enter neurons, propagate and produce neurotoxic assemblies.  
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Huntington’s disease (HD) is an autosomal genetically inherited neurodegenerative disorder 
characterized by debilitating motor, psychiatric, and cognitive symptoms (Bates et al., 2015, 
Gosh and Tabrizi, 2018). Expansion of a CAG repeat (>35) in the exon 1 of huntingtin HTT 
gene, which translates into an abnormal polyglutamine (polyQ) tract, is the underlying cause of 
Huntington’s Disease (HD). (The Huntington’s Disease Collaborative Research Group, 1993). 
Mutant HTT exon-1 (HTTex1) released by the enzymatic cleavage of full-length protein and/or 
by aberrant splicing of mutant HTT mRNA, is the most aggregation-prone species, accumulates 
in the brains of HD patients and is sufficient to induce severe HD-like pathology in animal 
models (DiFiglia et al., 1997, Davies et al., 1997, Lunkes et al., 2002, Sathasivam, et al., 2010, 
Bates et al., 2015, Neueder et al., 2018, Yang et al., 2020). The aggregation of mutant HTTex1 
produces a heterogeneous mixture of assemblies including oligomers, fibrils and inclusion 
bodies, which may have different biological properties (Arrasate et al., 2004, Kim et al., 2016, 
Sahoo et al., 2016, Bäuerlein et al., 2017). For example, transient expression of mutant HTTex1 
in culture models revealed that the accumulation of soluble oligomeric species coincide with 
neurotoxicity (Arrasate et al., 2004, Nucifora et al., 2012). On the other hand, fibrils of HTTex1 
may interact with cellular membranes and disrupt their architectures and vital functions 
(Bäuerlein et al., 2017). The promiscuous interaction of misfolded mutant HTTex1 with cellular 
proteins may also contribute to the heterogeneity of assemblies and toxicity spectrum (Kim et al., 
2016, Wanker et al., 2019).  
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The oligomerization of mutant HTTex1 in vitro occurs by a stepwise mechanism and is 
influenced by several factors such as interaction with biological membranes and the formation of 
an oligomeric seed structure, which acts as a nucleating agent and accelerates aggregation 
(Pandey et al., 2017, Tao et al., 2019). Seed structures may also assemble in vivo, however, little 
is known about their structures and roles in aggregation and toxicity. Seeding-competent mutant 
HTT assemblies capable of promoting the aggregation of monomeric HTTex1 in vitro and in cell 
models have been isolated from the brains of HD animal models and postmortem brain 
homogenates and cerebrospinal fluids (CSF) of HD patients. In these studies, the levels of 
mutant HTT seeds positively correlated with disease severity in the HD patients (Morozova et 
al., 2015, Ast et al., 2018, Lee et al., 2020). Interestingly, similar to other amyloidogenic proteins 
such as α-synuclein and Tau, mutant HTTex1 may have the propensity to propagate by a prion-
like mechanism (Jucker and Walker, 2018, Pearce and Kopito, 2018, Masnata et al., 2019). For 
example, mutant HTTex1 assemblies spread between neurons in the brains of Drosophila models 
of HD and form aggregates by recruiting monomeric HTTex1 (Pearce et al, 2018). Moreover, 
cerebrospinal fluids (CSF) of HD patients seed mammalian cells engineered to express mutant 
HTTex1-EGFP and induce protein aggregation (Tan et al., 2015, Lee et al., 2020). These 
encouraging findings provide a new direction in HD research and may have implications for the 
spread and propagation of neurotoxic mutant HTT assemblies in HD.  
The neurodegenerative aspect of HD may release various mutant HTT assemblies in the 
circulation and CSF. Moreover, HTT is actively and passively secreted from cultured cells and 
neurons in the HD animal models (Trajkovic, et al., 2017, Caron et al., 2021).  Indeed, the levels 
of mutant HTT in plasma and CSF of HD patient are being used as biomarkers evaluating the 
efficacy of therapeutics in HD patients (Tabrizi et al., 2019). While few recent studies 
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demonstrate that extracellular amyloidogenic HTTex1 fibrils have the propensity to enter cell 
lines and neurons in mouse models (Masnata et al., 2019, Lee et al., 2020), the biological 
properties of extracellular mutant HTT seeds including the mechanism for cell entry, 
amplification, and neurotoxicity remain to be investigated. Here, we report that some assemblies 
in the sonicated recombinant HTTex1 fibrils preferentially enter human neurons and produce 
neurotoxic assemblies by recruiting endogenous HTT with normal polyQ length. Using a panel 
of novel anti-HTTex1 monoclonal antibodies and mutagenesis, we further show that 
conformations within the N-terminal 17 amino acids and proline-rich domains (PRD) of HTT are 
critical for the neural entry and amplification of seeding-competent HTTex1. These studies 
support the notion that some extracellular assemblies of HTTex1 with tropism for neurons may 
contribute to the accumulation of toxic assemblies. 
2. Materials and Methods 
2. 1. Antibodies  
PHP1-PHP3 mouse monoclonal antibodies (mAbs) were reported previously (Ko et al., 2018). 
The new PHP5 and PHP6 mAbs were isolated from a mAb library made to the N-17 peptide 
with 7 glutamines at the C-terminus, and PHP7-PHP10 were produced to sonicated mutant 
HTTex1 fibrils (Khoshnan et al., in preparation). Clones were selected from each hybridoma 
library for binding to HTT species by ELISA, Western blots and dot blots as previously 
described ((Ko et al., 2018), (Supplementary figure 2A and B)). Antibody to beta III Tubulin was 
from Abcam (Cat# ab18207, 1:1000). The secondary antibodies were goat anti-rabbit Alexa 
Fluor 488 Cat# A32731, goat anti-mouse Alexa Fluor 488, Cat# A28175, goat anti-mouse Alexa 
Fluor 594 Cat# A32742, Life Technologies, 1:1000 and goat anti-mouse, Horseradish Peroxidase 
(HRP) Cat# A16072, Invitrogen, 1:10000.  
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2.2. Dot blot assay  
A strip of PVDF membrane was pre-wet in 100% methanol for 15 s, soaked in water for 2 min 
and equilibrated for 5 min in TBS-T (0.05 % Tween, pH 7.4). A sheet of Whatman filter paper 
was then soaked in TBS-T and placed on a dry sheet of Whatman filter paper on top of some dry 
paper towels. The PVDF membrane was placed on top of filter stack and 2 µL of each protein 
was spotted on a pre-marked grid. The membrane was dried to fix proteins to it for 1.5 h at room 
temperature. The membrane was then blocked, probed with each indicated primary antibody 
followed by treatment with goat-anti-mouse HRP secondary antibody, and detected by the 
addition of chemiluminescent agent ClarityTM Western ECL Substrate (Cat# 1705060, Bio-rad).  
2. 3. Engineering of recombinant PHP2 antibody and lentivirus production 
 
The DNA fragments encoding the antigen binding domain of VH and VL of PHP2 were 
amplified from a cDNA library made to mRNA of parental hybridoma by standard PCR methods 
using mixture of commercial primers and sequenced (Khoshnan et al., 2002). The amplified 
cDNAs were assembled into an IgG2 backbone (provided by Dr. Alejandro Balazs at the Ragon 
Institute of MGH, MIT and Harvard) by Gibson assembly (New England biolabs) and 
subsequently cloned into a lentiviral vector (FUGW). Control and PHP2 recombinant viral 
particles were produced in HEK-293 cells as described previously (Khoshnan and Patterson, 
2012). Viral titers were determined using a GFP lentivirus as a reference. Subsequently, 
MESC2.10 neural progenitor cells (NPCs) were transduced at multiplicity of (2:1). Supernatant 
of neurons form the transduced NPCs were tested for antibody secretion and PHP2 antibody 
binding to HTT fibrils was confirmed by Western blots.  
2.4. Purification of thioredoxin (TRX)-HTTex1 fusion protein 
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Expression and purification of wild-type (Q25) and mutant (Q46) HTTex1 fusion proteins has 
been described previously (Bugg et al., 2012, Isas et al., 2015, Isas et al., 2017). Briefly, bacterial 
cell pellet containing the expressed fusion protein (6XHis-TRXA-HTTex1/or HTTex1-111C 
variant for labeling) were lysed and cell debris were removed by centrifugation.  The clarified 
lysates containing the fusion protein were loaded onto Ni-column (NiHis60 super flow resin) and 
washed with a low concentration of imidazole saline buffer. The fusion protein was eluted with 
high concentration of imidazole saline buffer. The HTTex1-111C variant was first labeled with 
AlexaFlour 555 (1 to 3 molar ratios for 3hr), diluted 1 to 10 with low salt buffer, loaded on to 
anionic exchange resin (Mono Q), and further fractionated with a linear gradient (25mM to 1M 
salt) to remove free label and elute the labelled Alexa sample.  
2.5. Preparation and purification of HTTex1 fibrils 
Monomer HTTex1 (Q25 or Q46) ((HTTex1) (Q46_111Alexa555)) was produced, by the 
removal of the TRX fusion tag enzymatically (EKMax), followed by separation on reverse phase 
column (C4) with an acetonitrile gradient as previously described (Pandey et al., 2018). HTTex1 
fibrils or (Alexa555 labelled fibrils) were made by first solubilizing lyophilized protein powder 
from previous step in 0.5% TFA (v/v) in methanol, determined the concentration, and removed 
the organic solvent by gentle N2 gas stream, resulting in a thin clear protein film. The protein 
film was resuspended in ice cold buffer (20 mM Tris pH7.4, 150 mM NaCl) and adjusted to 
between 20 to 25 μM concentration.  Fibrils reaction started by adding 1% (molar ratio) of 
sonicated HTTex1 seeds as previously described (Isas et al., 2017) and incubated at 4°C 
overnight. In a separate reaction, 20% Alexa labelled fibrils were made by adding 4 to 5 μM of 
HTTex1_111alexa555 solubilized monomer to the Httex1 unlabeled sample. After overnight 
incubation fibrils were harvested by ultra-centrifugation, and the resulting translucent pellets 
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were resuspended in TFA:H20 (1:4000) at a concentration of 1mg/ml and fragmented using 
sonication.  Mutant HTTex1 in which each residue in PRD domain was replaced with a Pro 
residue (HTTex1mL17) was generated for probing the binding site of PHP1 and PHP2 as 
recently reported (Ko et al., 2018). HTTex1mL17 Fibrils were made as described for the 
HTTex1 in the section above.  
2. 6. Treatment of cells with HTTex1 seeds  
Neurons were derived from embryonic human MESC2.10, IPSC-derived neuronal progenitor 
cells (NPCs) (provided by Dr. Alysson Muotri, UCSD) according to standard protocols 
(Khoshnan et al., 2012). Astrocytes were derived from IPSCs by culturing progenitors in 
DMEM/F12 supplemented with N2 growth factor and 0.5% FBS (Cat# ES-009-B, Millipore) for 
14-20 days. Caco-2 and Neuro2A were obtained from ATCC and cultured according to 
instructions provided. Each line was treated with 10 nM of sonicated HTTx1 fibrils for the 
indicated time points in the figure legends and processed for immunocytochemistry and confocal 
microscopy as described previously (Khoshnan, et al., 2012). For antibody inhibition assay, 10 
nM of sonicated fibrils were pre-incubated with 1 μg of each antibody clone indicated in the 
figures for 2 hr at RT and subsequently added to growth medium and processed as above.     
2.7. In vitro seeding assay with HTT species  
Sonicated HTTx1 seeds (10 ng) were incubated with recombinant WT HTTex1 monomers or 
100 µg of total protein from human neural lysates for 4 hr at 25˚C with continuous agitation. 
Semi-denaturing detergent agarose gel electrophoresis (SDD-AGE) was performed to examine 
the amplified products as described previously (Halfman and Lindquist, 2008) with some 
modifications. Briefly, seeded lysates were loaded in a 1.5% agarose gel in 1X Tris-acetate-
EDTA (TAE) (Tris base, glacial acetic acid and EDTA) containing a final concentration of 0.1% 
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SDS. Using 1X Tris-buffered saline (TBS), downward capillary action was used to transfer 
protein to immune-blot PVDF membrane (Merck cat#  IPVH00010). Membranes were blocked 
with 5% milk in wash buffer (0.05% Tween in PBS) and incubated with the indicated primary 
anti-HTT antibodies overnight at 4˚C. HRP-conjugated goat anti-mouse secondary antibody 
(1:10000) in wash buffer was then applied for 2 h and developed with ECL substrate and X-ray 
film. 
2. 8. Western blot analysis of seeded neurons 
MESC2.10 derived neurons grown in 10 cm culture plates were treated with 10 nM of sonicated 
HTTex1 fibrils  for 24 hr. The seeded neurons were harvested and lysed in RIPA buffer (50 mM 
Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.1% SDS and protease inhibitor). 50 µg of 
neuronal lysate and corresponding mHTTex1 seed were boiled for 5 min with sample loading 
buffer and loaded into a 4-20 % polyacrylamide gel (SDS-PAGE, Criterion Bio-Rad)  to detect 
monomeric endogenous HTT or by semi-denaturing detergent agarose (1.5%) gel electrophoresis 
(SDD-AGE) to  probe for the seeded aggregated products. Different antibodies indicated in the 
figures and figure legends were used for detecting different species of HTT.  
For proteinase K resistance assay, 0.1 µg of mHTTex1 seed or 50 µg of seeded neuronal 
lysate was incubated with varying doses of proteinase K (0 to 0.5 µg/mL, Qiagen) for 30 min at 
25ºC and heat inactivated at 75ºC for 10 min. The digested products were analyzed by SDD-
AGE and western blot. PHP2 was used as the detection antibody. 
2.9. Immunodepletion of HTT in neural lysates 
 Immunodepletion of HTT was performed by incubating100 µg of neuronal lysates with 2 µg of 
each anti-HTTex1 or control  antibodies overnight at 4˚C with rotation. The antibody-HTT 
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complexes were precipitated with protein G covalently conjugated to magnetic beads (Thermo 
Scientific, P188803). The HTT-depleted lysates were seeded with 10 ng of sonicated HTTex1 
fibrils for 4 hr at 25˚C with rotation. SDD-AGE was performed to detect the amplified products. 
The primary antibody used for western blot analysis was PHP1, which is reactive to mutant HTT 
aggregates in HD animal models (Ko et al., 2018). 
2.10. Sucrose fractionation of HD brains 
 Synaptosome and ER/Golgi fractions were prepared from individual mouse forebrains according 
a recently published method (Mastro et al., 2020). Briefly,  forebrains of 9-month old ZQ175 HD 
mice were dissected from each animal, rinsed in Buffer A (0.32 M sucrose, 1 mM NaHCO3, 1 
mM MgCl2, 0.5 mM CaCl2, 0.1 mM phenylmethylsulphonyl chloride (PMSF, Sigma Millipore, 
St. Louis, MO). Each individual forebrain was homogenized in Buffer A (10% w/v, 4.5 ml for 
mice) with 12 up and down strokes of a Teflon/glass homogenizer at 900 rpm. Homogenates 
were subjected to centrifugation at 1400g for 10 min. The pellet was resuspended in Buffer A to 
10% w/v (3.8 ml), homogenized (three strokes at 900 rpm) and subjected to centrifugation at 710 
g for 10 min. The final resultant pellet (P1) was harvested as a crude fraction containing the 
nuclei. The two supernatants (S1) were combined and subjected to centrifugation at 13,800g for 
10 min. The resulting pellet (P2) was resuspended in Buffer B (0.32 M sucrose, 1 mM NaHCO3; 
2 ml for mice), homogenized with 6 strokes at 900 rpm in a Teflon/glass homogenizer, and 
layered onto a discontinuous sucrose gradient (equal parts 0.32M, 0.85 M, 1.0 M, and 1.2 M 
sucrose in 1 mM NaH2CO3 buffer (10.5 ml). Gradients were subjected to centrifugation for 2 
hours at 82,500g in a swinging bucket rotor. The bands between 0.32M and 0.85M sucrose (light 
membranes, Myelin), 0.85M and 1.0M sucrose (light membranes, Endoplasmic Reticulum, 
Golgi), 1.0M and 1.2M sucrose sections (Synaptosomes).  
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2.11. Assessment of seeding activity of protease-resistant brain fractions  
Synaptosome and ER/Golgi fractions isolated from ZQ175 mouse brain by sucrose fractionation 
were dialyzed using Slide-A-Lyzer Dialysis Cassette (Thermo Fisher Scientific, 66203). The 
dialyzed mouse brain fractions isolated by sucrose fractionation were incubated with 0.01 µg/mL 
of Proteinase K at 37˚C for 1 hr and heat inactivated at 75˚C for 10 min. MESC2.10 neurons in 
12-well plate were then incubated with 50 µg of each fraction at 37˚C for 24 hr. This was 
followed by immunocytochemistry to examine for the presence of seeding-competent fibrils and 
assembly formation. 
2.12. Immunocytochemistry and nuclear damage quantifications 
 Cells were fixed with 4% formaldehyde in PBS at room temperature for 30 min. After 
permeabilization and blocking (70% methanol in PBS, at least 1h at -20˚C, 10% normal goat 
serum and 2% BSA in PBS, 30 min at room temperature); cells were incubated overnight with 
specific primary antibodies at 4˚C. After washing in PBS, cells were incubated with appropriate 
AF 594 or 488 conjugated secondary antibodies in blocking solution for 2 hr at RT, washed and 
mounted in Vectashield with DAPI. At least 6 random pictures were captured using a Leica SP8 
confocal microscope and analyzed using LAS X software. For each picture, the total number of 
intact cells as well as those with fragmented nuclei were counted. The percent of neurons with 
intracellular HTT aggregates (seeded neurons) and neurons with nuclear fragmentation was then 
calculated for each condition and plotted. 
2.13. Caspase-3 Assays 
 Neurons were treated with 10 nM of sonicated HTTex1 seeds for 24 hr. PHP1 antibody (1:1000) 
was used to detect intracellular HTT fibrils and caspase-3 activity in untreated and treated 
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neurons was monitored by immunocytochemistry using anti-caspase-3 antibody (Abcam, Cat# 
32351, 1:1000). Images were captured using a Leica SP8 confocal microscope and analyzed by 
LAS X software. Neurons with aggregates and active caspase-3 were quantified  as described in 
the section above. 
2.14. Statistical analysis 
For pairwise comparisons, Student’s t-test was used and analysis of variance (ANOVA), 
followed by the Tukey’s post hoc test was performed for multiple comparisons. P values <0.05 
were considered as significant and for all results, values are presented as the mean and error bars 
indicate standard error of the mean (SEM). Statistical significance was assigned as ∗ = P < 0.05, 
∗∗ = P < 0.01, ∗∗∗ = P < 0.001. 
3. Results 
3.1. HTTex1 assemblies preferentially enter human neurons and amplify 
To explore the seeding properties of recombinant HTTex1 (46Qs), we incubated pre-
assembled fibrils (Isas et al., 2017) with human neurons and examined for uptake and 
amplification. Mutant HTTex1 fibrils bound to neural surfaces but were not taken up. However, 
sonication of the fibrils generated smaller species (HTTex1 seeds), which seeded neurons 
derived from an embryonic neuronal progenitor cell line (MESC2.10) and formed assemblies 
detected by antibodies specific to the proline-rich domain (PRD) of HTTex1 (Fig. 1A, B). To 
verify the amplification of HTTex1 seeds, we examined equivalent ratio of the seeds and lysates 
of seeded neurons by semi-denaturing detergent agarose gel electrophoresis (SDD-AGE) 
followed by Western Blots (WBs) and found a heterogeneous mixture of assemblies larger than 
~ 250 kDa reactive to anti-PRD antibodies (Fig. 1C). The neural seeding and amplification of 
HTTex1 was progressive and rapid affecting ~60% of the cells by 24 hr (Fig. 1B). Similar to the 
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HTTex1 seeds, the amplified products in neuronal lysates displayed partial resistance to 
proteinase-K (PK) digestion indicating the formation of complex assemblies (Fig. 1D and E, 
respectively). Sonicated fibrils of WT HTTex1 (25Q) also entered neurons and amplified 
suggesting polyQ expansion is not essential for the seeding properties of HTTex1 assemblies 
(Supplementary fig. 1A). Collectively, these results suggest that seeding-competent HTTex1 
assemblies in the sonicated HTTex1 fibrils may preferentially enter neurons and amplify 
producing a heterogeneous mixture of aggregates.  
To determine whether  the seeds enter neurons directly, we covalently conjugated the 
seeds with Alexa 555 fluorophore and added to neurons. By 6 hr post-treatment, labeled HTTex1 
predominantly accumulated in the nuclei and increased by longer incubation (Fig. 2A, left panels 
and B). Notably, the number of neurons with detectable labeled HTTex1 seeds were maximal by 
~12 hr of incubation but staining of the seeded neurons by the anti-HTT antibody  showed ~ 4-
fold increase in reactivity by 24 hr post treatment (Fig. 2A, right panels and B). One possibility is 
that undetectable levels of the labeled HTTx1 seeds may enter some neurons and promote 
aggregation, alternatively the newly formed  assemblies may spread to the neighboring neurons 
and propagate. Interestingly, although the HTTex1 seeds entered neurons derived from induced 
pluripotent stem cells (IPSCs),  they did not affect astrocytes produced from the same line even 
after incubation for up to 4 days in culture (Fig. 2C and D, respectively). We also examined 
human epithelial cell lines such as Caco-2 or mouse neuro2A cell line but found no evidence for 
entry and aggregation (Supplementary fig. 1C and D, respectively). These results suggest that 
seeding-competent HTTex1 assemblies may preferentially enter neurons and accumulate in the 
nucleus.  
3.2. Mutant HTTex1 seeds produce neurotoxic assemblies 
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Importantly, HTTex1 seeds-triggered aggregation promoted robust and progressive nuclear 
fragmentation, which could be visualized and quantified in the DAPI- stained images (Fig. 3A 
and B). To confirm the toxicity of HTTex1 seeds, we stained treated neurons for caspase-3 
activation and found it activated in the majority of neurons with aggregates (Fig. 3C-E). These 
findings indicate that the amplification of  extracellular HTTex1 seeds in neurons produces toxic 
assemblies and may constitute a pathogenic aspect of mutant HTTex1.   
3.3. Neural entry of HTTex1 seeds deplete endogenous HTT  
            To better characterize the mutant HTTex1-induced assembly formation in neurons, we 
examined the lysates of seeded neurons by SDD-AGE followed by WBs using a panel of  
antibodies reactive to the PRD of HTTex1 seeds (Supplementary fig. 2A and 2B). High 
molecular weight assemblies (>250 kDa) were detected by several anti-HTT monoclonal 
antibodies (PHP1, PHP2, PHP7, PHP8), whereas two clones (PHP9 and PHP10) reacted poorly 
(Figs. 1E, 4A). A likely possibility is that the conformations for the binding of PHP9 and PHP10 
may be altered and/or masked in the amplified products. Notably, examination of the seeded 
neural lysates with antibodies binding to monomeric HTT species (PHP1, PHP5, 2166) revealed 
depletion of endogenous full-length and N-terminal fragments of HTT (Fig. 4B, arrows). This 
raised the question of whether the HTTex1 seeds may recruit the endogenous HTT as a substrate. 
Sequencing the cDNA of HTT in MESC2.10 progenitors revealed 2 copies with  24Qs and 25Qs 
(data not shown). To confirm that HTTex1 seeds can recruit HTT fragments with normal polyQ 
length, we developed an in vitro amplification assay using monomeric recombinant WT HTTex1 
(25Qs) as a substrate. Examined by SDD-AGE, we found that the seeds recruited monomeric 
HTTex1 and produced assemblies, which migrated similar to those formed in neurons (Figs. 4C 
and 4A, respectively). Interestingly, HTTex1 seeds also triggered assembly formation in the 
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neural lysates (Fig. 4D, the lysates with several anti-HTT antibodies before adding the seeds. 
Depletion with the anti-N17 antibodies (PHP5 and PHP6) or clones reactive to the PRD of 
HTTex1 (PHP1, PHP2 and PHP10) (Supplementary fig. 2A and B) significantly reduced protein 
aggregation triggered by the HTTex1 seeds (Figure. 4D, Supplementary fig. 2C). Depletion with 
other anti-HTT antibodies such as PHP3, which binds to polyQ/polyP junction of HTT (Ko et al., 
2018) or PHP8 (Supplementary fig. 2A) did not affect the mutant HTTex1-induced aggregation 
(Supplementary fig. 2C). These studies suggest that HTTex1 seeds may recruit the N-terminal 
fragments of HTT to propagate in neurons. Given that the 2166 antibody, which binds to epitope 
outside exon1, does not react with the amplified products (Fig. 4B), it is difficult to determine 
whether the HTTex1 seeds also recruit full-length HTT. However, reduction in the levels of the 
microtubule-associated protein Tuj-1 indicates that HTTex1 seeds may recruit neuronal proteins 
which may include full-length HTT and those interacting with it (Fig. 4B, bottom panels).  
3.4. Antibodies to conformations in the N17 and PRD block neural entry and amplification of 
HTTex1 seeds  
To identify the epitopes regulating the neural entry and propagation of HTTex1, we 
incubated the HTTex1 seeds with antibodies reactive to various conformations (Supplementary 
fig. 2A) and added the seed-antibody complexes to neuronal cultures. We found that pre-
incubation of HTTex1 seeds with antibodies to the N17 domain (PHP5, PHP6) and clones 
reactive to the PRD (PHP1, PHP2, and PHP10) blocked neural entry, amplification and nuclear 
damage. Importantly, two anti-PRD antibodies PHP7-PHP9, which also bind the seeds 
(Supplementary fig. 2B), were ineffective suggesting that distinct conformations or regions in the 
PRD of HTTex1 seeds may be critical for entry (Fig. 5A and B, Supplementary fig. 3). HTTex1 
seeds pre-incubated with the N17 antibodies (PHP5, PHP6) remained bound to neurons but did 
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not enter. One possibility is that HTTex1 interacts with neurons using epitopes within the PRD, 
however, antibodies binding to N17 of HTTex1 seeds may prevent entry by affecting yet 
unidentified step. To verify that the epitope in the PRD is critical for the neural entry and 
amplification of HTTex1, we mutated the known binding site of the protective antibodies PHP1 
and PHP2 (L17 domain, Supplementary fig. 2A), (Ko et al., 2018). Consistent with the antibody 
inhibition assays, sonicated fibrils of the PRD-mutated HTTex1 (HTTex1mL17) were incapable 
of seeding neurons and inducing nuclear damage (Fig. 5C and D). Collectively, these results 
suggest that specific conformations in the N17 and PRD are critical for the neural entry and 
propagation of HTTex1 seeds.  
3.5. Neurons secreting anti-HTT antibodies are immune to HTTex1 seeding 
To explore the therapeutic application of antibodies preventing the neural entry of 
extracellular HTTex1, we engineered neurons to secrete PHP2 antibodies. MESC2.10 NPCs 
were transduced with a lentivirus encoding full-length PHP2 antibody. Secreted antibodies from 
neurons react with the HTTex1 seeds (Supplementary fig. 4). We found that neurons secreting 
the recombinant PHP2 are resistant to seeding by the HTTex1 since the entry, amplification and 
nuclear damage were significantly reduced (Fig. 5E and F). These data further confirm the 
inhibitory properties of PHP2 and  support the potential use of recombinant antibodies to prevent 
seeding by extracellular HTTex1 assemblies in HD models.  
3. 6. Seeding-competent mutant HTT species accumulate in the brains of  ZQ175 HD mice  
To determine whether seeding-competent mutant HTT species accumulate in vivo, brain 
homogenates of 9-month old ZQ175 HD mice were centrifuged on sucrose gradients optimized 
to enrich for myelin, ER/Golgi and synaptosome fractions (Mastro et al., 2020) and examined for 
the presence of mutant HTT by SDD-AGE and WB (Figure. 6A). Aliquots of ER/Golgi and 
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synaptosome fractions, which had the most HTT species, were subsequently examined for entry 
and propagation in neurons. We found mutant HTT assemblies predominantly in the 
synaptosome fractions of some animals were capable of seeding neurons (Fig. 6B), however, the 
seeding activity was not consistently present in the preparations from various cohorts of similar 
aged animals (Fig. 6C, top panels). We predicted that similar to antibody inhibition assays (Fig. 
5A), HTT-interacting proteins may interfere with the neuronal entry of mutant HTT. Since 
HTTex1 seeds and those amplified in neurons are resistant to partial proteinase K (PK) digestion 
(Fig. 1D and E), we performed partial PK digestion of ER/Golgi and synaptosome fractions prior 
to testing in neurons. Interestingly, PK treatment significantly enhanced the seeding activity of 
mutant HTT in the synaptosome and to some extent in the ER/Golgi fractions (Fig. 6C, bottom 
panels). We predict that PK treatment may expose the critical conformation of mutant HTT seeds 
by digesting the interacting proteins; alternatively, PK treatment may directly produce seeding-
competent species by cleaving mutant HTT. Similar to recombinant HTTex1, seeding by the 
mutant HTT assemblies from HD animals induced nuclear fragmentation (Fig. 6D). These data 
suggest that seeding-competent mutant HTT species may accumulate in the brains of HD 
animals and are consistent with the recent findings where the mutant HTT isolated from the 
brains of ZQ175 HD mice seeded HEK-293 cells expressing mutant HTTex1-EGFP (Lee et al., 
2020).  
 
4. Discussion  
This study was designed to investigate the seeding properties of extracellular HTTex1 assemblies 
in cell models. The major findings were preferential neural entry of seeding-competent  HTTex1 
species in the sonicated fibrils, nuclear localization, amplification, and induction of neurotoxicity 
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exemplified by depletion of HTT, nuclear damage and caspase-3 activation (Fig. 7). Our studies 
also  implicate the N17 and a prominent epitope within the PRD of HTTex1 regulating the neural 
entry and amplification of HTTex1 seeds. These findings and the notion that similar seeding-
competent mutant HTT may exist in vivo suggest that neural uptake and amplification of 
extracellular amyloidogenic HTTex1 assemblies may constitute a pathogenic pathway in HD.  
Recent studies suggest that HTTex1 assemblies are taken up by a range of cell lines 
(Masnata, et al., 2019, Lee, et al. 2020). Our studies indicate that some species in the sonicated 
HTTex1 fibrils preferentially enter neurons, which is more in line with the neurodegenerative 
aspect of HD. In our hands, HTTex1 seeds or fibrils did not affect astrocytes or non-neuronal cell 
lines that were tested. The preference of our HTTex1 seeds for neurons may be due to their 
structural and biophysical properties imparted by the methods used to prepare the fibrils and/or 
the evolution of novel conformations induced by sonication. As we are optimizing protocols to 
assemble and stabilize various oligomeric structures of HTTex1 (Isas, et al., 2019), we may 
ultimately be able to explore the biological properties of different assemblies of HTTex1 without 
sonication. This will include structural identity as well as tropism for non-neuronal cells or 
various neuronal lineages including medium-sized spiny neurons, which appear to degenerate 
first in HD patients (Bates et al., 2015).  The efficient entry and amplification of HTTex1 seeds 
in our assays is also noteworthy where up to 60% of neurons are affected within 24 hr (Fig. 1A 
and B). The short incubation period may be due to presence of active receptor(s) on neurons 
mediating efficient entry and/or the abundance of substrates including the endogenous HTT 
species for amplification. HTT is abundant in neurons and reduction in the levels of full-length 
and N-terminal  HTT species in the seeded neurons along with their depletion in the lysates 
seeding assays  are consistent with a potential role of endogenous HTT (25Qs) as a substrate for 
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the HTTex1 seeds (Fig. 4). Notably, the HTTex1 seeds initially accumulate in the nuclei of 
neurons (Fig. 2A), which may be the initial site for amplification. However, since HTT is present 
in several cellular organelles and due to nuclear-cytoplasmic shuttling properties of HTTex1 
(Saudou and Humbert, 2016), multi-focal seeding/amplification may occur. The findings that 
HTT levels are reduced in the seeded neurons and the amplified products are reactive to several 
anti-HTT antibodies support a homotypic seeding mechanism (Isas et al., 2017, Ast, et al., 2018, 
Pandey et al., 2018). Whether heterotypic seeding as demonstrated with α-synuclein and Tau 
(Jucker and Walker, 2018), also occurs with the HTTex1 seeds in neurons remains to be 
investigated. However, amyloidogenic HTTex1 species are known to interact with hundreds of 
cellular proteins, which may also be incorporated into assemblies detected in our assays (Kim et 
al., 2016, Wanker et al., 2019). The promiscuous interaction of HTTex1 seeds with other 
neuronal proteins may also contribute to the short incubation period required for assembly 
formation. 
 Unraveling the robust neurotoxic aspect of extracellular HTTex1 is another novelty of 
our work, which might have been difficult to observe previously. Our success might have been a 
combination of sonicated unbundled HTTex1 fibrils and human neurons with abundant 
endogenous HTT as  several other cell types were resistant to seeds uptake. The pathogenic 
manifestations of HTTex1 seeds in neurons included nuclear damage, caspase-3 activation and 
depletion of HTT, which is vital to neuronal survival. Nuclear/DNA damage is detected in the 
immune cells of prodromal HD patients and is recognized as a pathogenic modifier of HD 
(Askeland et al., 2018, Castaldo et al., 2019). The mechanism of nuclear damage in our assays 
remains to be investigated. However, HTTex1 seeds may sequester critical proteins including the 
endogenous HTT essential for maintaining the nuclear integrity (Kim et al., 2016, Gao et al., 
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2019, Wanker et al., 2019). HTT is a component of the ATM (ataxia telangiectasia mutated) 
enzymatic machinery responsible for sensing and repairing DNA damage induced by oxidative 
stress (Maiuri, et al., 2017). HTT also binds to a complex consisting of RNA polymerase II, 
CREB binding protein (CBP), ataxin 3, and the DNA repair enzyme polynucleotide-kinase -3-
phosphatase (PNKP), which detects and repairs DNA damage generated during transcription 
elongation (Gao et al., 2019). Thus, depletion of HTT by the HTTex1 seeds may inactivate two 
prominent sensors of DNA damage and make the nucleus susceptible to insults. The activation of 
caspase-3 may further contribute to HTTex1-induced nuclear damage and apoptosis. Activated 
caspase-3 is detected in the brains of HD patients and cleaves HTT in human neurons (Kim et 
al., 2001, Khoshnan et al., 2009). Moreover, intact HTT is an inhibitor of caspase-3 and reducing 
its levels promotes cell death (Zhang et al., 2006). While dissecting the precise mechanism of 
how HTTex1 seeds induce neurotoxicity remain to be characterized, we predict that depletion of 
endogenous of HTT may impair various physiological pathways in the target neurons, which is 
manifested as nuclear crumbling and death.  
The preference of the HTTex1 seeds for neurons highlights the potential involvement of   
a cell surface receptor mediating the entry, which is the subject of future studies. On the HTTex1 
seeds however, we have found critical epitopes responsible for binding to neuronal surfaces. The 
antibody inhibition assays and mutagenesis studies indicate that conformations reactive to 
PHP1/PHP2 antibodies within the PRD (Ko et al., 2018) are important for the neural entry and 
amplification of HTTex1 seeds. The inability of other PRD-reactive monoclonal antibodies 
(PHP7-PHP9) to block neural seeding (Fig. 5, Suppl. Fig. 3) reinforces the specificity of novel 
conformations. Although antibodies to N17 domain also prevented the entry of HTTex1, the 
seed-antibody complexes remained avidly attached to neurons (Fig. 5, Supplementary fig. 3). We 
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predict that N17 domain is not essential for neuronal binding but the seed-antibody complexes 
are too large to enter. Alternatively, the N17 domain may be required for events downstream of 
binding such as transport across neuronal membranes given its high affinity for binding to lipid 
bilayers (Tao et al., 2019). Recent studies indicate that phosphorylation of residues in the N17 or 
removal of N17 enhances the neural uptake and nuclear accumulation of HTTex1 fibrils, which 
also induce neuronal death (Vieweg, et al., 2021). Thus, N17 may regulate some aspect of  
HTTex1 neuronal entry; albeit  serving an inhibitory function.  On the other hand, a recent study 
also found that the anti-N17 antibodies did not prevent the mutant HTTex1 seeding of 
engineered HEK-293 cells expressing HTTex-1-EGFP cells (Lee et al., 2020). One reason for the 
discrepancy with our findings may be the variations in the conformations in the N17 to which 
different antibodies bind. Alternately, the role of N17 in the cell entry of HTTex1 seeds may 
vary in different paradigms, i.e. neurons versus epithelial cells. Thus, further studies are needed 
to verify the role of N17 in the neural entry of HTTex1 seeds. Our data however, are consistent 
with the role of PRD in the HTTex1 seeding HEK-293 cells expressing HTTex1-EGFP (Lee, et 
al., 2020). Thus,  conformations binding the PHP1 and PHP2 antibodies are candidate 
pathogenic epitopes and may be useful targets to develop reagents for preventing neural seeding 
in vivo. It is encouraging that engineered neurons secreting recombinant PHP2 antibodies are 
immune to  HTTex1 seeds. This may serve as a platform to test other recombinant antibodies for 
seeding inhibition and ultimately deliver full-length recombinant antibodies to HD models for 
therapeutic evaluation.  
In conclusion, our studies reveal that extracellular seeding-competent HTTex1 may 
preferentially seed neurons and amplify. To our knowledge this is the first robust neuronal 
seeding assay where neurotoxic assemblies form by depletion of the normal endogenous HTT. 
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We have further identified the structural determinants of HTTex1 essential for neural seeding. 
The neuronal assays and reagents including the inhibitory antibodies provide a useful platform to 
further characterize the biological properties of different HTTex1 seeds, monitor disease 
progression in HD using fluids such as plasma or CSF, and to further develop compounds, which 
may prevent the spread and amplification of neurotoxic species in HD. The potential existence of 
novel receptors for the neural entry of HTTex1 species, which is being investigated by our labs, 
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Figure Legends 
Figure 1. HTTex1 species enter and amplify in neurons. (A) Human neurons derived from 
MESC2.10 embryonic stem cell line were treated with mutant HTTex1 fibrils or sonicated fibrils 
(seeds), incubated for the indicated time points and processed for ICC using anti-PRD PHP1 
antibody (HTT). Insert in the bottom right  panel is a magnified  seeded neuron. (B) 
Quantification of seeded neurons at different time points. (C). Examination of the lysates of 
seeded neurons 24 hr post-treatment by SDD-AGE detected by PHP1. HTTex1 seed were 
adjusted to the amounts in the lysates loaded  to determine the extent of amplification. (D &E) 
HTTx1 seeds  and its amplified products in MESC 2.10 derived neurons are partially resistant to 
proteinase K (PK) digestion. Seeds (D) and neural lysates from seeded neurons (E) were treated 
with an increasing concentration of PK and examined by SDD-AGE and WBs using PHP2 
antibody. Data are mean ± SEM; **P<0.01, ***P<0.001. 
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Figure 2. HTTex1 seeds accumulate in the nuclei of neurons. (A) Fluorophore-labelled (Alexa 
555) HTTex1 seeds were added to human neurons for the indicated time points and processed for 
ICC using PHP1 antibody. Confocal images in the left panels show the nuclear localization of 
labelled HTTex1 seeds and in the right panels are merged images of labelled HTTex1 and 
amplified species detected by PHP1 antibody. Inserts in the top and bottom panels are magnified 
neurons. (B) is the quantification of neurons with the labelled HTTex1 (left columns) and 
neurons labelled with PHP1 antibody (right columns). (C&D) Human neurons from IPSC-
derived neuronal progenitors (left panels) or IPSC-derived astrocytes (right panels) were treated 
with HTTex1 fibrils or sonicated fibrils for 24 hr and processed similar to part (A). Neurons 
were stained with PHP1 and anti-Tuj-1  and astrocytes were stained with PHP1 and anti-GFAP. 
Data show mean ± SEM; **P<0.01, ***P<0.001. 
Figure 3. HTTex1 assemblies cause nuclear damage and caspase-3 activation. (A) For a better 
contrast, black and white images of DAPI stained neurons treated with HTTex1 fibrils or 
sonicated fibrils for the indicated time points are shown to display the progressive nuclear 
damage. (B) Quantification of DNA damage in neurons seeded with unsonicated or sonicated 
mutant HTTex1 fibrils. (C) Confocal images of neurons with active caspase-3, which was 
induced in neurons treated with the sonicated HTTex1 seeds.  Graphs in D and E show 
quantification of neurons with HTT aggregates and active caspase-3, respectively. Data are 
expressed as mean ± SEM; ***P<0.001. 
Figure 4.  HTTex1 seeds recruit endogenous HTT species to form assemblies. (A) SDD-AGE 
analysis followed by WBs of control neuronal  lysates (C) or lysates of seeded  neurons (SD) 
with sonicated HTTex1 fibrils probed with the indicated anti-HTT antibodies. Part B  is SDS-
PAGE of similar lysates probed with antibodies reactive to soluble HTT. Arrowheads indicate 
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depletion of endogenous full-length and N-terminal fragments of HTT in the lysates of seeded 
neurons. (C) Seeding of recombinant WT HTTex1 monomers by the HTTex1 seeds (S). Products 
were examined by SDD-AGE and WB using PHP1 antibody. (D) Neural lysates were seeded 
with the mutant HTTex1 seeds. Lane 1 is seed alone and lane 2 is seeded neuronal lysate. The 
indicated antibodies below each lane were used to deplete the endogenous HTT species before 
seeding. The binding epitopes of PHP antibodies are shown in supplementary fig. 2A. 
Figure 5. Antibodies to N17 and PRD of HTTex1 block neural seeding. (A) HTTex1 seeds were 
pre-incubated with the antibodies indicated on top of each panel, subsequently added to neurons 
and incubated for 24 hr. Samples were processed for ICC, stained with PHP1 and examined by a 
confocal microscope. Panel B is the quantification of fragmented nuclei in each condition. (C)  
HTTex1 seeds or  those generated  from HTTex1 with mutated PRD (HTTx1mL17) were added 
to neurons and processed as in A. Anti-N17 antibody PHP5 was used to detect the amplified 
products. Panel D is the quantification of fragmented nuclei in each condition. (E) MESC2.10 
neurons engineered to secret control or PHP2 recombinant antibodies (Lenti-PHP2) were treated 
with the HTTex1 seeds, incubated for 24 hr, processed for ICC using PHP1 antibody and 
examined by a confocal microscope. Panel F is the quantification of  fragmented nuclei in each 
condition.  Data show mean ± SEM; ***P<0.001. 
Figure 6.  Mutant HTT seeds accumulate in the brains of ZQ175 HD mice. (A) Fractionation of 
mouse brains on sucrose gradients and examination by SDD-AGE and WB.  HTT was detected 
by PHP1 antibody. (B)  Dialyzed aliquots of each fraction (50 μg) were sonicated and added into 
human neurons derived from MESC2.10 and incubated for 24 hr. Neurons were processed for 
ICC and stained with PHP1 antibody. Part C is similar fractions as in A from different cohorts of 
mice treated with proteinase K (PK) or untreated and processed similar as in part B. Images were 
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captured with a confocal microscope. (D) Quantification of seeded neurons with fragmented 
nuclei in each condition is shown. Data show mean ± SEM; ***P<0.001. 
Figure 7. Schematic representation of the extracellular HTTex1 journey in neurons. HTTex1 
seeds potentially bind to a surface receptor to enter neurons and ultimately accumulate in the 
nucleus. Subsequently, the seeds may recruit the endogenous HTT fragments and other neural 
proteins to amplify. Amplified products induce neurotoxicity potentially by caspase-3 activation 
and depletion of HTT.   
 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted April 18, 2021. ; https://doi.org/10.1101/2021.04.16.440200doi: bioRxiv preprint 
